No Data
Meihao Medical Calls 2026 AGM and Seeks Fresh Share Issue Mandate
MEIHAO GROUP: Annual Report 2025
Meihao Group (01947.HK) narrowed its full-year loss to RMB 14.34 million.
Meihao Group (01947.HK) announced its 2025 financial results, reporting revenue of RMB 102 million (hereinafter the same), representing a year-on-year increase of 36.2%. The net loss narrowed from RMB 32.42 million in the previous year to RMB 14.34 million, with a loss per share of RMB 0.0246. No final dividend was declared.
MEIHAO GROUP: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025
Meihao Medical Sets March 2026 Board Meeting to Approve 2025 Results and Consider Dividend
Meihao Group (01947.HK): Estimated annual net loss of approximately RMB 13.1 million to RMB 19.8 million
Gelonghui, March 13th丨Meihao Group (01947.HK) announced that the group expects to record a net loss of approximately RMB 13.1 million to approximately RMB 19.8 million for the fiscal year ending December 31, 2024, compared to a loss of approximately RMB 32.6 million in the previous year. The Board believes that the reduction in losses is primarily attributable to the net impact of the following factors (among others): (i) a significant increase in the group’s revenue scale, with the continuous expansion of business scale leading to economies of scale gradually becoming evident, effectively diluting fixed costs such as depreciation and rent, and significantly improving overall profitability; (ii) expenses related to share-based payments showing a marked decrease.